Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Colombo

Showing results (141-150 of 169) with videos related to

Pageof 17
Sort By:
Actas Urologicas Espanolas|March 25, 2017
Medical-surgical activity and the current state of training of urology residents in Spain: Results of a national surveyM E Rodríguez-Socarrás, J Gómez Rivas, M García-Sanz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 6, 2025
Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trialsApril W Armstrong, Mark Lebwohl, Richard B Warren, et al.
Critical Care Explorations|July 19, 2021
Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial CohortChristopher J Colombo, Rhonda E Colombo, Ryan C Maves, et al.
Open Forum Infectious Diseases|December 8, 2021
Predictive Value of an Age-Based Modification of the National Early Warning System in Hospitalized Patients With COVID-19Ryan C Maves, Stephanie A Richard, David A Lindholm, et al.
JAMA Dermatology|November 27, 2024
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical TrialsApril W Armstrong, Mark Lebwohl, Richard B Warren, et al.
Dermatology and Therapy|January 13, 2022
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 TrialDiamant Thaçi, Bruce Strober, Kenneth B Gordon, et al.
Transplantation Proceedings|September 15, 2012
Extracorporeal lung perfusion and ventilation to improve donor lung function and increase the number of organs available for transplantationF Valenza, L Rosso, S Gatti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic DiversitySimon D Pollett, Stephanie A Richard, Anthony C Fries, et al.
The Journal of Infectious Diseases|July 31, 2021
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System BeneficiariesNusrat J Epsi, Stephanie A Richard, Eric D Laing, et al.
European Journal of Heart Failure|August 6, 2024
Ventilation strategies in cardiogenic shock: Insights from the AltShock-2 registryAlice Sacco, Andrea Montisci, Giovanni Tavecchia, et al.
Pageof 17

Showing results (141-150 of 169) with videos related to

Sort By:
Pageof 17
Actas Urologicas Espanolas|March 25, 2017
Medical-surgical activity and the current state of training of urology residents in Spain: Results of a national surveyM E Rodríguez-Socarrás, J Gómez Rivas, M García-Sanz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 6, 2025
Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trialsApril W Armstrong, Mark Lebwohl, Richard B Warren, et al.
Critical Care Explorations|July 19, 2021
Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial CohortChristopher J Colombo, Rhonda E Colombo, Ryan C Maves, et al.
Open Forum Infectious Diseases|December 8, 2021
Predictive Value of an Age-Based Modification of the National Early Warning System in Hospitalized Patients With COVID-19Ryan C Maves, Stephanie A Richard, David A Lindholm, et al.
JAMA Dermatology|November 27, 2024
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical TrialsApril W Armstrong, Mark Lebwohl, Richard B Warren, et al.
Dermatology and Therapy|January 13, 2022
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 TrialDiamant Thaçi, Bruce Strober, Kenneth B Gordon, et al.
Transplantation Proceedings|September 15, 2012
Extracorporeal lung perfusion and ventilation to improve donor lung function and increase the number of organs available for transplantationF Valenza, L Rosso, S Gatti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2021
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic DiversitySimon D Pollett, Stephanie A Richard, Anthony C Fries, et al.
The Journal of Infectious Diseases|July 31, 2021
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System BeneficiariesNusrat J Epsi, Stephanie A Richard, Eric D Laing, et al.
European Journal of Heart Failure|August 6, 2024
Ventilation strategies in cardiogenic shock: Insights from the AltShock-2 registryAlice Sacco, Andrea Montisci, Giovanni Tavecchia, et al.
Pageof 17